Envestnet Asset Management’s PennyMac Financial PFSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,987
Closed -$494K 4618
2025
Q3
$494K Buy
+3,987
New +$431K ﹤0.01% 3771
2024
Q1
Sell
-3,351
Closed -$296K 4258
2023
Q4
$296K Sell
3,351
-10,268
-75% -$771K ﹤0.01% 3630
2023
Q3
$907K Sell
13,619
-88,452
-87% -$6.36M ﹤0.01% 2882
2023
Q2
$7.18M Sell
102,071
-699,349
-87% -$44.3M ﹤0.01% 1494
2023
Q1
$5.28M Buy
801,420
+790,151
+7,012% +$48.9M ﹤0.01% 1632
2022
Q4
$638K Buy
11,269
+1,754
+18% +$92.9K ﹤0.01% 2952
2022
Q3
$408K Buy
9,515
+575
+6% +$30.1K ﹤0.01% 3147
2022
Q2
$391K Sell
8,940
-1,015
-10% -$47.9K ﹤0.01% 3197
2022
Q1
$530K Sell
9,955
-6,661
-40% -$403K ﹤0.01% 3093
2021
Q4
$1.16M Buy
16,616
+4,356
+36% +$287K ﹤0.01% 2533
2021
Q3
$749K Sell
12,260
-2,249
-16% -$143K ﹤0.01% 2728
2021
Q2
$895K Sell
14,509
-1,084
-7% -$65.9K ﹤0.01% 2615
2021
Q1
$1.04M Buy
15,593
+7,868
+102% +$488K ﹤0.01% 2377
2020
Q4
$507K Buy
+7,725
New +$460K ﹤0.01% 2651

Other funds holding PFSI

Envestnet Asset Management's PFSI Position: Q4 2025 in Review

Envestnet Asset Management sold out of PennyMac Financial (PFSI) in Q4 2025, closing a stake of 3,987 shares — an estimated $494K sold.

Envestnet Asset Management first reported a position in PFSI in Q4 2020 and held it in 14 quarters. The position peaked at $7.18M in Q2 2023. 264 funds tracked by Wall St. Rank hold PFSI as of Q4 2025.

  • Envestnet Asset Management reported no remaining PennyMac Financial position as of Q4 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 3,987 PennyMac Financial shares in Q4 2025, an estimated $494K.
  • Envestnet Asset Management first reported a position in PennyMac Financial in Q4 2020 and held it in 14 quarters.
  • Envestnet Asset Management's PennyMac Financial position peaked at $7.18M in Q2 2023.
  • 264 funds tracked by Wall St. Rank held PennyMac Financial as of Q4 2025.

Based on Envestnet Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.